Brookstone Capital Management

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1599584 WHEATON, IL

Position in UTHR

as of Mar 31, 2026 · filed Apr 16, 2026 Compact

Position Value

$2,651,213

-$575,356 QoQ

Shares Held

4,471

-32.5% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2025

5 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Brookstone Capital Management holds $4,588,273 across 4 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (57.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp This page	4,471	$2,651,213
2	HROW	Harrow, Inc.	28,884	$1,018,449
3	NBIX	Neurocrine Biosciences Inc	5,050	$665,287
4	ZTS	Zoetis Inc.	2,143	$253,324

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,651,213	4,471	-32.5%	Shares	Sole	2026-04-16
2025-12-31	$3,226,569	6,622	+25.4%	Shares	Sole	2026-01-15
2025-09-30	$2,213,428	5,280	+7.1%	Shares	Sole	2025-10-15
2025-06-30	$1,416,922	4,931	+2.8%	Shares	Sole	2025-07-30
2025-03-31	$1,479,079	4,798	—	Shares	Sole	2025-04-29
No filing history on record for this holder in this stock.